[1]
May, K.L.; Silhavy, T.J. Making a membrane on the other side of the wall. Biochim. Biophys. Acta, 2017, 1862, 1386-1393.
[2]
Chaturvedi, D.; Mahalakshmi, R. Transmembrane β-barrels: evolution, folding and energetics. Biochim. Biophys. Acta, 2017, 1859, 2467-2482.
[3]
Remaut, H.; Fronzes, R. Bacterial membranes; Horizon Scientific Press: Poole, 2014.
[4]
Zipfel, P.F.; Hallström, T.; Riesbeck, K. Human complement control and complement evasion by pathogenic microbes - tipping the balance. Mol. Immunol., 2013, 56, 152-160.
[5]
Narita, S-I.; Tokuda, H. Bacterial lipoproteins; biogenesis, sorting and quality control. Biochim. Biophys. Acta, 2017, 1862, 1414-1423.
[6]
Gondwe, E.N.; Molyneux, M.E.; Goodall, M.; Graham, S.M.; Mastroeni, P.; Drayson, M.T.; MacLennan, C.A. Importance of antibody and complement for oxidative burst and killing of invasive nontyphoidal Salmonella by blood cells in Africans. Proc. Natl. Acad. Sci. USA, 2010, 107, 3070-3075.
[7]
Gil-Cruz, C.; Bobat, S.; Marshall, J.L.; Kingsley, R.A.; Ross, E.A.; Henderson, I.R.; Leyton, D.L.; Coughlan, R.E.; Khan, M.; Jensen, K.T.; Buckley, C.D.; Dougan, G.; MacLennan, I.C.M.; López-Macías, C.; Cunningham, A.F. The porin OmpD from nontyphoidal Salmonella is a key target for a protective B1b cell antibody response. Proc. Natl. Acad. Sci. USA, 2009, 106, 9803-9808.
[8]
Cunningham, A.F.; Gaspal, F.; Serre, K.; Mohr, E.; Henderson, I.R.; Scott-Tucker, A.; Kenny, S.M.; Khan, M.; Toellner, K-M.; Lane, P.J.L.; MacLennan, I.C.M. Salmonella induces a switched antibody response without germinal centers that impedes the extracellular spread of infection. J. Immunol., 2007, 178, 6200-6207.
[9]
Widal, F.M. Serodiagnostic de la fiévre typhoide a-propos d'uve modification par MMC Nicolle et al. Halipie. Bull. Soc. Med. Hop, 1896, 13, 561-566.
[10]
Ismail, A.; Kader, Z.S.; Kok-Hai, O. Dot enzyme immunosorbent assay for the serodiagnosis of typhoid fever. Southeast Asian J. Trop. Med. Public Health, 1991, 22, 563-566.
[11]
Cho, Y.; Park, S.; Barate, A.K.; Truong, Q.L.; Han, J.H.; Jung, C-H.; Yoon, J.W.; Cho, S.; Hahn, T-W. Proteomic analysis of outer membrane proteins in Salmonella enterica Enteritidis. J. Microbiol. Biotechnol., 2015, 25, 288-295.
[12]
Bai, J.; Kim, S.I.; Ryu, S.; Yoon, H. Identification and characterization of outer membrane vesicle-associated proteins in Salmonella enterica serovar Typhimurium. Infect. Immun., 2014, 82, 4001-4010.
[13]
Cho, Y.; Sun, J.; Han, J.H.; Jang, J.H.; Kang, Z.W.; Hahn, T-W. An immunoproteomic approach for characterization of the outer membrane proteins of Salmonella gallinarum. Electrophoresis, 2014, 35, 888-894.
[14]
Ferrer-Navarro, M.; Ballesté-Delpierre, C.; Vila, J.; Fàbrega, A. Characterization of the outer membrane subproteome of the virulent strain Salmonella typhimurium SL1344. J. Proteomics, 2016, 146, 141-147.
[15]
Dudek, B.; Krzyżewska, E.; Kapczyńska, K.; Rybka, J.; Pawlak, A.; Korzekwa, K.; Klausa, E.; Bugla-Płoskońska, G. Proteomic analysis of outer membrane proteins from Salmonella enteritidis strains with different sensitivity to human serum. PLoS One, 2016, 11e0164069
[16]
Chooneea, D.; Karlsson, R.; Encheva, V.; Arnold, C.; Appleton, H.; Shah, H. Elucidation of the outer membrane proteome of Salmonella enterica serovar Typhimurium utilising a lipid-based protein immobilization technique. BMC Microbiol., 2010, 10, 44.
[17]
Majowicz, S.E.; Musto, J.; Scallan, E.; Angulo, F.J.; Kirk, M.; O’Brien, S.J.; Jones, T.F.; Fazil, A.; Hoekstra, R.M. International collaboration on enteric disease ‘Burden of Illness’ studies. The global burden of nontyphoidal Salmonella gastroenteritis. Clin. Infect. Dis., 2010, 50, 882-889.
[18]
Popoff, M.Y.; Le Minor, L. Antigenic formulas of the Salmonella serovars, 9th ed.; World Health Organization Collaborating Centre for Reference and Research on Salmonella, Pasteur Institute, Paris, 2007.
[19]
Shelobolina, E.S.; Sullivan, S.A.; O’Neill, K.R.; Nevin, K.P.; Lovley, D.R. Isolation, characterization, and U(VI)-reducing potential of a facultatively anaerobic, acid-resistant bacterium from low-pH, nitrate- and U(VI)-contaminated subsurface sediment and description of Salmonella subterranea sp. nov. Appl. Environ. Microbiol., 2004, 70, 2959-2965.
[21]
Parker, C.T.; Tindall, B.J.; Garrity, G.M. International code of nomenclature of prokaryotes. Int. J. Syst. Evol. Microbiol., 2016, 69(1A), S1-S111.
[23]
Kenneth, J.; Ryan, M.D.C.; George Ray, M.D. Sherris Medical Microbiology. An Introduction to Infectious Diseases. Medical Publishing Division, 4th ed; McGraw-Hill, 2004.
[25]
Darwin, K.H.; Miller, V.L. Molecular basis of the interaction of Salmonella with the intestinal mucosa. Clin. Microbiol. Rev., 1999, 12, 405-428.
[27]
Kariuki, S.; Gordon, M.A.; Feasey, N.; Parry, C.M. Antimicrobial resistance and management of invasive Salmonella disease. Vaccine, 2015, 33, C21-C29.
[28]
Boyd, D.; Cloeckaert, A.; Chaslus-Dancla, E.; Mulvey, M.R. Characterization of variant Salmonella genomic island 1 multidrug resistance regions from serovars Typhimurium DT104 and Agona. Antimicrob. Agents Chemother., 2002, 46, 1714-1722.
[29]
Kempf, I.; Jouy, E.; Chauvin, C. Colistin use and colistin resistance in bacteria from animals. Int. J. Antimicrob. Agents, 2016, 48, 598-606.
[30]
Directive 98/8/EC of the European Parliament and of the Council of 16 February 1998 concerning the placing of biocidal products on the market. J. Eur. Commun., 1998, Vol. 41.
[31]
European Food Safety Authority and European Centre for Disease Prevention and Control (EFSA and ECDC).European Union summary report on trends and sources of zoonoses, zoonotic agents and food-borne outbreaks in 2016. EFSA J., 2018, 16(12)e5500
[32]
Yu, C-Y.; Chou, S-J.; Yeh, C-M.; Chao, M-R.; Huang, K-C.; Chang, Y-F.; Chiou, C-S.; Weill, F-X.; Chiu, C-H.; Chu, C-H.; Chu, C. Prevalence and characterization of multidrug-resistant (type ACSSuT) Salmonella enterica serovar Typhimurium strains in isolates from four gosling farms and a hatchery farm. J. Clin. Microbiol., 2008, 46, 522-526.
[33]
Threlfall, E.J.; Frost, J.A.; Ward, L.R.; Rowe, B. Increasing spectrum of resistance in multiresistant Salmonella Typhimurium. Lancet, 1996, 347, 1053-1054.
[34]
Cavaco, L.M.; Hasman, H.; Xia, S.; Aarestrup, F.M. qnrD, a novel gene conferring transferable quinolone resistance in Salmonella enterica serovar Kentucky and Bovismorbificans strains of human origin. Antimicrob. Agents Chemother., 2009, 53, 603-608.
[35]
Ellington, M.J.; Ekelund, O.; Aarestrup, F.M.; Canton, R.; Doumith, M.; Giske, C.; Grundman, H.; Hasman, H.; Holden, M.T.G.; Hopkins, K.L.; Iredell, J.; Kahlmeter, G.; Köser, C.U.; MacGowan, A.; Mevius, D.; Mulvey, M.; Naas, T.; Peto, T.; Rolain, J-M.; Samuelsen, Ø.; Woodford, N. The role of whole genome sequencing in antimicrobial susceptibility testing of bacteria: Report from the EUCAST Subcommittee. Clin. Microbiol. Infect., 2017, 23, 2-22.
[36]
Hendriksen, R.S.; Leekitcharoenphon, P.; Mikoleit, M.; Jensen, J.D.; Kaas, R.S.; Roer, L.; Joshi, H.B.; Pornruangmong, S.; Pulsrikarn, C.; Gonzalez-Aviles, G.D.; Reuland, E.A. Naiemi, Al, N.; Wester, A.L.; Aarestrup, F.M.; Hasman, H. Genomic dissection of travel-associated extended-spectrum-beta-lactamase-producing Salmonella enterica serovar Typhi isolates originating from the Philippines: a one-off occurrence or a threat to effective treatment of typhoid fever? J. Clin. Microbiol., 2015, 53, 677-680.
[37]
Hopkins, K.L.; Wootton, L.; Day, M.R.; Threlfall, E.J. Plasmid-mediated quinolone resistance determinant qnrS1 found in Salmonella enterica strains isolated in the UK. J. Antimicrob. Chemother., 2007, 59, 1071-1075.
[38]
Moskowitz, S.M.; Brannon, M.K.; Dasgupta, N.; Pier, M.; Sgambati, N.; Miller, A.K.; Selgrade, S.E.; Miller, S.I.; Denton, M.; Conway, S.P.; Johansen, H.K.; Høiby, N. PmrB mutations promote polymyxin resistance of Pseudomonas aeruginosa isolated from colistin-treated cystic fibrosis patients. Antimicrob. Agents Chemother., 2012, 56, 1019-1030.
[39]
Guo, L.; Lim, K.B.; Gunn, J.S.; Bainbridge, B.; Darveau, R.P.; Hackett, M.; Miller, S.I. Regulation of lipid a modifications by Salmonella typhimurium virulence genes phoP-phoQ. Science, 1997, 276, 250-253.
[40]
Anjum, M.F.; Duggett, N.A.; AbuOun, M.; Randall, L.; Nunez-Garcia, J.; Ellis, R.J.; Rogers, J.; Horton, R.; Brena, C.; Williamson, S.; Martelli, F.; Davies, R.; Teale, C. Colistin resistance in Salmonella and Escherichia coli isolates from a pig farm in Great Britain. J. Antimicrob. Chemother., 2016, 71, 2306-2313.
[41]
Liu, Y-Y.; Wang, Y.; Walsh, T.R.; Yi, L-X.; Zhang, R.; Spencer, J.; Doi, Y.; Tian, G.; Dong, B.; Huang, X.; Yu, L.F.; Gu, D.; Ren, H.; Chen, X.; Lv, L.; He, D.; Zhou, H.; Liang, Z.; Liu, J.H.; Shen, J. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: A microbiological and molecular biological study. Lancet Infect. Dis., 2016, 16, 161-168.
[42]
Thanh, D.P.; Tuyen, H.T.; Nguyen, T.N.T.; Wick, R.R.; Thwaites, G.; Baker, S.; Holt, K.E. Inducible colistin resistance via a disrupted plasmid-borne mcr-1 gene in a 2008 Vietnamese Shigella sonnei isolate. J. Antimicrob. Chemother., 2016, 71, 2314-2317.
[43]
Tse, H.; Yuen, K-Y. Dissemination of the mcr-1 colistin resistance gene. Lancet Infect. Dis., 2016, 2, 145-146.
[44]
European Medicines Agency. Updated advice on the use of colistin products in animals within the European Union: development of resistance and possible impact on human and animal health.EMA/CVMP/CHMP/231573/2016, 27 July, 2016.
[45]
Herrero-Fresno, A.; Wallrodt, I.; Leekitcharoenphon, P.; Olsen, J.E.; Aarestrup, F.M.; Hendriksen, R.S. The role of the St313-Td gene in virulence of Salmonella typhimurium ST313. PLoS One, 2014, 9e84566
[46]
Parsons, B.N.; Humphrey, S.; Salisbury, A.M.; Mikoleit, J.; Hinton, J.C.D.; Gordon, M.A.; Wigley, P. Invasive non-typhoidal Salmonella typhimurium ST313 are not host-restricted and have an invasive phenotype in experimentally infected chickens. PLoS Negl. Trop. Dis., 2013, 7e2487
[47]
Futoma-Kołoch, B. Bacterial outer membrane proteins - dependent complement activation. J. Mol. Immunol., 2016, 1, 1000e104.
[48]
Bennett, K.M.; Rooijakkers, S.H.M.; Gorham, R.D. Let’s tie the knot: marriage of complement and adaptive immunity in pathogen evasion, for better or worse. Front. Microbiol., 2017, 8, 944.
[49]
Haas, P-J.; van Strijp, J. Anaphylatoxins: their role in bacterial infection and inflammation. Immunol. Res., 2007, 37, 161-175.
[50]
Garcia, B.L.; Zwarthoff, S.A.; Rooijakkers, S.H.M.; Geisbrecht, B.V. Novel evasion mechanisms of the classical complement pathway. J. Immunol., 2016, 197, 2051-2060.
[51]
Merle, N.S.; Noe, R.; Halbwachs-Mecarelli, L.; Fremeaux-Bacchi, V.; Roumenina, L.T. Complement system part II: role in immunity. Front. Immunol., 2015, 6, 257.
[52]
Rosbjerg, A.; Genster, N.; Pilely, K.; Garred, P. Evasion mechanisms used by pathogens to escape the lectin complement pathway. Front. Microbiol., 2017, 8, 1212.
[53]
Fernández, F.J.; Gómez, S.; Vega, M.C. Pathogens’ toolbox to manipulate human complement. Sem. Cell Develop. Biol., 2017, S1084-9521(17), 30138-30146.
[54]
Nicod, C.; Banaei-Esfahani, A.; Collins, B.C. Elucidation of host-pathogen protein–protein interactions to uncover mechanisms of host cell rewiring. Curr. Opin. Microbiol., 2017, 39, 7-15.
[55]
Heffernan, E.J.; Reed, S.; Hackett, J.; Fierer, J.; Roudier, C.; Guiney, D. Mechanism of resistance to complement-mediated killing of bacteria encoded by the Salmonella Typhimurium virulence plasmid gene Rck. J. Clin. Invest., 1992, 90, 953-964.
[56]
Mambu, J.; Virlogeux-Payant, I.; Holbert, S.; Grépinet, O.; Velge, P.; Wiedemann, A. An updated view on the Rck invasin of Salmonella: still much to discover. Front. Cell. Infect. Microbiol., 2017, 7, 500.
[57]
Gunn, J.S.; Alpuche-Aranda, C.M.; Loomis, W.P.; Belden, W.J.; Miller, S.I. Characterization of the Salmonella typhimurium pagC/pagD chromosomal region. J. Bacteriol., 1995, 177, 5040-5047.
[58]
Pulkkinen, W.S.; Miller, S.I. A Salmonella typhimurium virulence protein is similar to a Yersinia enterocolitica invasion protein and a bacteriophage lambda outer membrane protein. J. Bacteriol., 1991, 173, 86-93.
[59]
Miller, V.L.; Falkow, S. Evidence for two genetic loci in Yersinia enterocolitica that can promote invasion of epithelial cells. Infect. Immun., 1988, 56, 1242-1248.
[60]
Heffernan, E.J.; Harwood, J.; Fierer, J.; Guiney, D. The Salmonella Typhimurium virulence plasmid complement resistance gene Rck is homologous to a family of virulence-related outer membrane protein genes, including pagC and Ail. J. Bacteriol., 1992, 174, 84-91.
[61]
Haneda, T.; Okada, N.; Nakazawa, N.; Kawakami, T.; Danbara, H. Complete DNA sequence and comparative analysis of the 50-kilobase virulence plasmid of Salmonella enterica serovar Choleraesuis. Infect. Immun., 2001, 69, 2612-2620.
[62]
Nishio, M.; Okada, N.; Miki, T.; Haneda, T.; Danbara, H. Identification of the outer-membrane protein PagC required for the serum resistance phenotype in Salmonella enterica serovar Choleraesuis. Microbiol., 2005, 151, 863-873.
[63]
Mecsas, J.; Welch, R.; Erickson, J.W.; Gross, C.A. Identification and characterization of an outer membrane protein, OmpX, in Escherichia coli that is homologous to a family of outer membrane proteins including Ail of Yersinia enterocolitica. J. Bacteriol., 1995, 177, 799-804.
[64]
Ho, D.K.; Tissari, J.; Järvinen, H.M.; Blom, A.M.; Meri, S.; Jarva, H. Functional recruitment of human complement inhibitor C4B-binding protein to outer membrane protein Rck of Salmonella. PLoS One, 2011, 6e27546
[65]
Abed, N.; Grépinet, O.; Canepa, S.; Hurtado-Escobar, G.A.; Guichard, N.; Wiedemann, A.; Velge, P.; Virlogeux-Payant, I. Direct regulation of the pefI-srgC operon encoding the Rck invasin by the quorum-sensing regulator SdiA in Salmonella Typhimurium. Mol. Microbiol., 2014, 94, 254-271.
[66]
Parente, R.; Clark, S.J.; Inforzato, A.; Day, A.J. Complement factor H in host defense and immune evasion. Cell. Mol. Life Sci., 2017, 74, 1605-1624.
[67]
Rawal, N.; Rajagopalan, R.; Salvi, V.P. Stringent regulation of complement lectin pathway C3/C5 convertase by C4b-binding protein (C4BP). Mol. Immunol., 2009, 46, 2902-2910.
[68]
Hovingh, E.S.; van den Broek, B.; Jongerius, I. Hijacking complement regulatory proteins for bacterial immune evasion. Front. Microbiol., 2016, 7, 325.
[69]
Ho, D.K.; Jarva, H.; Meri, S. Human complement factor H binds to outer membrane protein Rck of Salmonella. J. Immunol., 2010, 185, 1763-1769.
[70]
Miller, V.L.; Beer, K.B.; Loomis, W.P.; Olson, J.A.; Miller, S.I. An unusual pagC:TnphoA mutation leads to an invasion- and virulence-defective phenotype in Salmonellae. Infect. Immun., 1992, 60, 3763-3770.
[71]
Guina, T.; Yi, E.C.; Wang, H.; Hackett, M.; Miller, S.I. A PhoP-regulated outer membrane protease of Salmonella enterica serovar Typhimurium promotes resistance to alpha-helical antimicrobial peptides. J. Bacteriol., 2000, 182, 4077-4086.
[72]
Ramu, P.; Lobo, L.A.; Kukkonen, M.; Bjur, E.; Suomalainen, M.; Raukola, H.; Miettinen, M.; Julkunen, I.; Holst, O.; Rhen, M.; Korhonen, T.K.; Lähteenmäki, K. Activation of pro-matrix metalloproteinase-9 and degradation of gelatin by the surface protease PgtE of Salmonella enterica serovar Typhimurium. Int. J. Med. Microbiol., 2008, 298, 263-278.
[73]
Haiko, J.; Laakkonen, L.; Juuti, K.; Kalkkinen, N.; Korhonen, T.K. The omptins of Yersinia pestis and Salmonella Enterica cleave the reactive center loop of plasminogen activator inhibitor 1. J. Bacteriol., 2010, 192, 4553-4561.
[74]
Järvinen, H.M.; Laakkonen, L.; Haiko, J.; Johansson, T.; Juuti, K.; Suomalainen, M.; Buchrieser, C.; Kalkkinen, N.; Korhonen, T.K. Human single-chain urokinase is activated by the omptins PgtE of Salmonella enterica and Pla of Yersinia pestis despite mutations of active site residues. Mol. Microbiol., 2013, 89, 507-517.
[75]
Ramu, P.; Tanskanen, R.; Holmberg, M.; Lähteenmäki, K.; Korhonen, T.K.; Meri, S. The surface protease PgtE of Salmonella enterica affects complement activity by proteolytically cleaving C3b, C4b and C5. FEBS Lett., 2007, 581, 1716-1720.
[76]
Zhou, Y.; Zhou, J.; Wang, D.; Gao, Q.; Mu, X.; Gao, S.; Liu, X. Evaluation of ompA and pgtE genes in determining pathogenicity in Salmonella enterica serovar Enteritidis. Vet. J., 2016, 218, 19-26.
[77]
Riva, R.; Korhonen, T.K.; Meri, S. The outer membrane protease PgtE of Salmonella enterica interferes with the alternative complement pathway by cleaving factors B and H. Front. Microbiol., 2015, 6, 63.
[78]
Schaller, J.; Gerber, S.; Kaempfer, U.; Lejon, S.; Trachsel, C. Human Blood Plasma Proteins; John Wiley & Sons: Chichester, UK, 2008.
[79]
Sukupolvi, S.; Vuorio, R.; Qi, S.Y.; O’Connor, D.; Rhen, M. Characterization of the traT gene and mutants that increase outer membrane permeability from the Salmonella typhimurium virulence plasmid. Mol. Microbiol., 1990, 4, 49-57.
[80]
Sukupolvi, S.; O’Connor, C.D. TraT lipoprotein, a plasmid-specified mediator of interactions between gram-negative bacteria and their environment. Microbiol. Rev., 1990, 54, 331-341.
[81]
Pramoonjago, P.; Kaneko, M.; Kinoshita, T.; Ohtsubo, E.; Takeda, J.; Hong, K.S.; Inagi, R.; Inoue, K. Role of TraT protein, an anticomplementary protein produced in Escherichia coli by R100 factor, in serum resistance. J. Immunol., 1992, 148, 827-836.
[82]
Sarowska, J.; Bugla-Płoskońska, G.; Futoma-Kołoch, B.; Drulis-Kawa, Z. The sensitivity level of Salmonella enterica ESBL+ transconjugants to normal human serum correlated with OMP band patterns obtained by SDS-PAGE. Adv. Clin. Exp. Med., 2010, 6, 669-677.
[83]
Futoma-Kołoch, B.; Bugla-Płoskońska, G.; Sarowska, J. In:Salmonella - distribution, adaptation, control measures and molecular technologies., Bassam A. Annous; Joshua B. ; Gurtler,; Ed.;. InTech, 2012, pp. 265-290.
[84]
Futoma-Kołoch, B.; Dudek, B.; Kapczyńska, K.; Krzyżewska, E.; Wańczyk, M.; Korzekwa, K.; Rybka, J.; Klausa, E.; Bugla-Płoskońska, G. Relationship of triamine-biocide tolerance of Salmonella enterica serovar Senftenberg to antimicrobial susceptibility, serum resistance and outer membrane proteins. Int. J. Mol. Sci., 2017, 18, 1459.
[85]
Bugla-Płoskońska, G.; Korzeniowska-Kowal, A.; Guz-Regner, K. Reptiles as a source of Salmonella O48-clinically important bacteria for children: the relationship between resistance to normal cord serum and outer membrane protein patterns. Microb. Ecol., 2011, 61, 41-51.
[86]
Parry, C.M. Antimicrobial drug resistance in Salmonella enterica. Curr. Opin. Infect. Dis., 2003, 16, 467-472.
[87]
Nishino, K.; Latifi, T.; Groisman, E.A. Virulence and drug resistance roles of multidrug efflux systems of Salmonella enterica serovar Typhimurium. Mol. Microbiol., 2006, 59, 126-141.
[88]
Miller, S.I. Antibiotic resistance and regulation of the gram-negative bacterial outer membrane barrier by host innate immune molecules. MBio, 2016, 7, e01541-e16.
[89]
Quinn, T.; O’Mahony, R.; Baird, A.W.; Drudy, D.; Whyte, P.; Fanning, S. Multi-drug resistance in Salmonella enterica: Efflux mechanisms and their relationships with the development of chromosomal resistance gene clusters. Curr. Drug Targets, 2006, 7, 849-860.
[90]
Nikaido, H. Multidrug efflux pumps of gram-negative bacteria. J. Bacteriol., 1996, 178, 5853-5859.
[91]
Horiyama, T.; Yamaguchi, A.; Nishino, K. TolC dependency of multidrug efflux systems in Salmonella enterica serovar Typhimurium. J. Antimicrob. Chemother., 2010, 65, 1372-1376.
[92]
Andersen, J.L.; He, G-X.; Kakarla, P. K C, R.; Kumar, S.; Lakra, W.S.; Mukherjee, M.M.; Ranaweera, I.; Shrestha, U.; Tran, T.; Varela, M.F. Multidrug efflux pumps from Enterobacteriaceae, Vibrio cholerae and Staphylococcus aureus bacterial food pathogens. Int. J. Environ. Res. Public Health, 2015, 12, 1487-1547.
[93]
Baucheron, S.; Chaslus-Dancla, E.; Cloeckaert, A. Role of TolC and parC mutation in high-level fluoroquinolone resistance in Salmonella enterica serotype Typhimurium DT204. J. Antimicrob. Chemother., 2004, 53, 657-659.
[94]
Tal, N.; Schuldiner, S. A Coordinated network of transporters with overlapping specificities provides a robust survival strategy. Proc. Natl. Acad. Sci. USA, 2009, 106, 9051-9056.
[95]
Murakami, S.; Nakashima, R.; Yamashita, E.; Matsumoto, T.; Yamaguchi, A. Crystal structures of a multidrug transporter reveal a functionally rotating mechanism. Nature, 2006, 443, 173-179.
[96]
Koronakis, V.; Li, J.; Koronakis, E.; Stauffer, K. Structure of TolC, the outer membrane component of the bacterial type I efflux system, derived from two-dimensional crystals. Mol. Microbiol., 1997, 23, 617-626.
[97]
Koronakis, V.; Sharff, A.; Koronakis, E.; Luisi, B.; Hughes, C. Crystal structure of the bacterial membrane protein TolC central to multidrug efflux and protein export. Nature, 2000, 405, 914-919.
[98]
Morona, R.; Manning, P.A.; Reeves, P. Identification and characterization of the TolC protein, an outer membrane protein from Escherichia coli. J. Bacteriol., 1983, 153, 693-699.
[99]
Higgins, M.K.; Bokma, E.; Koronakis, E.; Hughes, C.; Koronakis, V. Structure of the periplasmic component of a bacterial drug efflux pump. Proc. Natl. Acad. Sci. USA, 2004, 101, 9994-9999.
[100]
Wang, Z.; Fan, G.; Hryc, C.F.; Blaza, J.N.; Serysheva, I.I.; Schmid, M.F.; Chiu, W.; Luisi, B.F.; Du, D. An allosteric transport mechanism for the AcrAB-TolC multidrug efflux pump. eLife, 2017, 6, 11103.
[101]
Webber, M.A.; Bailey, A.M.; Blair, J.M.A.; Morgan, E.; Stevens, M.P.; Hinton, J.C.D.; Ivens, A.; Wain, J.; Piddock, L.J.V. The global consequence of disruption of the AcrAB-TolC efflux pump in Salmonella enterica includes reduced expression of SPI-1 and other attributes required to infect the host. J. Bacteriol., 2009, 191, 4276-4285.
[102]
Pagès, J-M.; James, C.E.; Winterhalter, M. The porin and the permeating antibiotic: a selective diffusion barrier in gram-negative bacteria. Nat. Rev. Microbiol., 2008, 6, 893-903.
[103]
Hu, W.S.; Lin, J-F.; Lin, Y-H.; Chang, H-Y. Outer membrane protein STM3031 (Ail/OmpX-Like Protein) plays a key role in the ceftriaxone resistance of Salmonella enterica serovar Typhimurium. Antimicrob. Agents Chemother., 2009, 53, 3248-3255.
[104]
Santiviago, C.A.; Fuentes, J.A.; Bueno, S.M.; Trombert, A.N.; Hildago, A.A.; Socias, L.T.; Youderian, P.; Mora, G.C. The Salmonella enterica sv. Typhimurium smvA, yddG and ompD (porin) genes are required for the efficient efflux of methyl viologen. Mol. Microbiol., 2002, 46, 687-698.
[105]
Pilonieta, M.C.; Erickson, K.D.; Ernst, R.K.; Detweiler, C.S. A protein important for antimicrobial peptide resistance, YdeI/OmdA, is in the periplasm and interacts with OmpD/NmpC. J. Bacteriol., 2009, 191, 7243-7252.
[106]
Zgurskaya, H.I.; Krishnamoorthy, G.; Ntreh, A.; Lu, S. Mechanism and function of the outer membrane channel TolC in multidrug resistance and physiology of Enterobacteria. Front. Microbiol., 2011, 2, 189.
[107]
Li, Q.; Hu, Y.; Wu, Y.; Wang, X.; Xie, X.; Tao, M.; Yin, J.; Lin, Z.; Jiao, Y.; Xu, L.; Jiao, X. Complete genome sequence of Salmonella enterica serovar Pullorum multidrug resistance strain S06004 from China. J. Microbiol. Biotechnol., 2015, 25, 606-611.
[108]
Usui, M.; Nagai, H.; Hiki, M.; Tamura, Y.; Asai, T. Effect of antimicrobial exposure on AcrAB expression in Salmonella enterica subspecies enterica serovar Choleraesuis. Front. Microbiol., 2013, 4, 53.
[109]
Feuerriegel, S.; Heisig, P. Role of global regulator rma for multidrug efflux-mediated fluoroquinolone resistance in Salmonella. Microb. Drug Resist., 2008, 14, 259-263.
[110]
Kalily, E.; Hollander, A.; Korin, B.; Cymerman, I.; Yaron, S. Mechanisms of resistance to linalool in Salmonella Senftenberg and their role in survival on Basil. Environ. Microbiol., 2016, 18, 3673-3688.
[111]
Solnik-Isaac, H.; Weinberger, M.; Tabak, M.; Ben-David, A.; Shachar, D.; Yaron, S. Quinolone resistance of Salmonella enterica serovar Virchow isolates from humans and poultry in Israel: evidence for clonal expansion. J. Clin. Microbiol., 2007, 45, 2575-2579.
[112]
Santiviago, C.A.; Toro, C.S.; Bucarey, S.A.; Mora, G.C. A Chromosomal Region Surrounding the ompD porin gene marks a genetic difference between Salmonella typhi and the majority of Salmonella serovars. Microbiol., 2001, 147, 1897-1907.
[113]
Toro, C.S.; Lobos, S.R.; Calderón, I.; Rodríguez, M.; Mora, G.C. Clinical isolate of a porinless Salmonella typhi resistant to high levels of chloramphenicol. Antimicrob. Agents Chemother., 1990, 34, 1715-1719.
[114]
Muriel Masi, J-M.P. Suppl 1: Structure, function and regulation of outer membrane proteins involved in drug transport in Enterobactericeae: the OmpF/C - TolC case. Open Microbiol. J., 2013, 7, 22-33.
[115]
Long, M.; Lai, H.; Deng, W.; Zhou, K.; Li, B.; Liu, S.; Fan, L.; Wang, H.; Zou, L. Disinfectant susceptibility of different Salmonella serotypes isolated from chicken and egg production chains. J. Appl. Microbiol., 2016, 121, 672-681.
[116]
Książczyk, M.; Krzyżewska, E.; Futoma-Kołoch, B.; Bugla-Płoskońska, G. Disinfectants - bacterial cells interactions in the view of hygiene and public health. Postepy Hig. Med. Dosw., 2015, 69, 1042-1055.
[117]
Futoma-Kołoch, B.; Książczyk, M. The risk of Salmonella resistance following exposure to common disinfectants: an emerging problem. Biol. Internat., 2013, 53, 54-66.
[118]
McDonnell, G.; Russell, A.D. Antiseptics and disinfectants: activity, action, and resistance. Clin. Microbiol. Rev., 1999, 12, 147-179.
[119]
McLaren, I.; Wales, A.; Breslin, M.; Davies, R. Evaluation of commonly-used farm disinfectants in wet and dry models of Salmonella farm contamination. Avian Pathol., 2011, 40, 33-42.
[120]
Dann, A.B.; Hontela, A. Triclosan: environmental exposure, toxicity and mechanisms of action. J. Appl. Toxicol., 2011, 31, 285-311.
[121]
Condell, O.; Power, K.A.; Händler, K.; Finn, S.; Sheridan, A.; Sergeant, K.; Renaut, J.; Burgess, C.M.; Hinton, J.C.D.; Nally, J.E.; Fanning, S. Comparative analysis of Salmonella susceptibility and tolerance to the biocide chlorhexidine identifies a complex cellular defense network. Front. Microbiol., 2014, 5, 373.
[122]
Shah, N.; Naseby, D.C. Efficacy of benzalkonium chloride against bioluminescent P. aeruginosa ATCC9027 constructs. Biosens. Bioelectron., 2017, 97, 8-15.
[123]
Carrique-Mas, J.J.; Marin, C.; Breslin, M.; McLaren, I.; Davies, R. A Comparison of the efficacy of cleaning and disinfection methods in eliminating Salmonella spp. from commercial egg laying houses. Avian Pathol., 2009, 38, 419-424.
[124]
Lin, W.; Guan, X.; Cao, J.; Niu, B.; Chen, Q. Bactericidal mechanism of glutaraldehyde-didecyldimethylammonium bromide as a disinfectant against Escherichia coli. J. Appl. Microbiol., 2017, 122, 676-685.
[125]
Endo, Y.; Tani, T.; Kodama, M. Antimicrobial activity of tertiary amine covalently bonded to a polystyrene fiber. Appl. Environ. Microbiol., 1987, 53, 2050-2055.
[126]
Linley, E.; Denyer, S.P.; McDonnell, G.; Simons, C.; Maillard, J-Y. Use of hydrogen peroxide as a biocide: new consideration of its mechanisms of biocidal Action. J. Antimicrob. Chemother., 2012, 67, 1589-1596.
[127]
Curiao, T.; Marchi, E.; Grandgirard, D.; León-Sampedro, R.; Viti, C.; Leib, S.L.; Baquero, F.; Oggioni, M.R.; Martinez, J.L.; Coque, T.M. Multiple adaptive routes of Salmonella enterica Typhimurium to biocide and antibiotic exposure. BMC Genomics, 2016, 17, 491.
[128]
Karatzas, K.A.G.; Randall, L.P.; Webber, M.; Piddock, L.J.V.; Humphrey, T.J.; Woodward, M.J.; Coldham, N.G. Phenotypic and proteomic characterization of multiply antibiotic-resistant variants of Salmonella enterica serovar Typhimurium selected following exposure to disinfectants. Appl. Environ. Microbiol., 2008, 74, 1508-1516.
[129]
Futoma-Kołoch, B.; Książczyk, M.; Korzekwa, K.; Migdał, I.; Pawlak, A.; Jankowska, M.; Kędziora, A.; Dorotkiewicz-Jach, A.; Bugla-Płoskońska, G. Selection and electrophoretic characterization of Salmonella enterica subsp. enterica biocide variants resistant to antibiotics. Pol. J. Vet. Sci., 2015, 18, 725-732.
[130]
Zhang, C.-Z.; Chen, P.-X.; Yang, L.; Li, W.; Chang, M.-X.; Jiang, H.-X. Coordinated expression of acrAB-tolC and eight other functional efflux pumps through activating ramA and marA in Salmonella enterica serovar Typhimurium. Microb. Drug Resist., 2017. mdr.2017.0086.
[131]
Bailey, A.M.; Constantinidou, C.; Ivens, A.; Garvey, M.I.; Webber, M.A.; Coldham, N.; Hobman, J.L.; Wain, J.; Woodward, M.J.; Piddock, L.J.V. Exposure of Escherichia coli and Salmonella enterica serovar Typhimurium to triclosan induces a species-specific response, including drug detoxification. J. Antimicrob. Chemother., 2009, 64, 973-985.
[132]
Whitehead, R.N.; Overton, T.W.; Kemp, C.L.; Webber, M.A. Exposure of Salmonella enterica serovar Typhimurium to high level biocide challenge can select multidrug resistant mutants in a single step. PLoS One, 2011, 6e22833
[133]
Rifai, N.; Gillette, M.A.; Carr, S.A. Protein biomarker discovery and validation: The long and uncertain path to clinical utility. Nat. Biotechnol., 2006, 24, 971-983.
Download PDF Flyer